Development of a Multipurpose GATEWAY-Based Lentiviral Tetracycline-Regulated Conditional RNAi System (GLTR)

por Sigl, Reinhard, Ploner, Christian, Shivalingaiah, Giridhar, Kofler, Reinhard, Geley, Stephan
Publicado 2014

BRCA1/2 and TP53 mutation status associates with PD-1 and PD-L1 expression in ovarian cancer

por Wieser, Verena, Gaugg, Inge, Fleischer, Martina, Shivalingaiah, Giridhar, Wenzel, Soeren, Sprung, Susanne, Lax, Sigurd F., Zeimet, Alain G., Fiegl, Heidelinde, Marth, Christian
Publicado 2018

BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer

por Tsibulak, Irina, Wieser, Verena, Degasper, Christine, Shivalingaiah, Giridhar, Wenzel, Sören, Sprung, Susanne, Lax, Sigurd F., Marth, Christian, Fiegl, Heidelinde, Zeimet, Alain G.
Publicado 2018

The miR-34 family and its clinical significance in ovarian cancer

por Welponer, Hannah, Tsibulak, Irina, Wieser, Verena, Degasper, Christine, Shivalingaiah, Giridhar, Wenzel, Sören, Sprung, Susanne, Marth, Christian, Hackl, Hubert, Fiegl, Heidelinde, Zeimet, Alain G.
Publicado 2020